EA
SPPI

Emerald Acquisition’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Emerald Acquisition’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.44M Sell
522,416
-209,051
-29% -$1.24M ﹤0.01% 1643
2016
Q2 		$4.81M Buy
+731,467
New +$5.17M 0.01% 1343

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Emerald Acquisition's SPPI Position: Q3 2016 in Review

Emerald Acquisition reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 29% in Q3 2016, selling an estimated $1.24M and leaving 522,416 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Emerald Acquisition first reported a position in SPPI in Q2 2016 and has held it in 2 quarters since. The position peaked at $4.81M in Q2 2016. 144 funds tracked by Wall St. Rank hold SPPI as of Q3 2016.

  • Emerald Acquisition held 522,416 shares of Spectrum Pharmaceuticals Inc worth $2.44M as of Q3 2016.
  • Emerald Acquisition sold 209,051 Spectrum Pharmaceuticals Inc shares in Q3 2016, an estimated $1.24M.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1643 holding.
  • Emerald Acquisition first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Spectrum Pharmaceuticals Inc position peaked at $4.81M in Q2 2016.
  • 144 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.